Ivabradine in Post-operative Junctional Ectopic Tachycardia (JET): Breaking New Ground

Area of Science:

• Pediatric Cardiology
• Cardiac Electrophysiology
• Post-operative Care

Background:

• Junctional ectopic tachycardia (JET) is the most frequent tachyarrhythmia post-pediatric open-heart surgery.
• JET can cause significant hemodynamic instability, necessitating aggressive management.
• Amiodarone is the current first-line pharmacologic treatment for post-operative JET.

Purpose of the Study:

• To evaluate the initial clinical experience with Ivabradine for managing post-operative JET in pediatric patients.
• To assess Ivabradine's efficacy and safety as an alternative to amiodarone.

Main Methods:

• Retrospective case records review of children diagnosed with post-operative JET between June 2018 and May 2019.
• Analysis of treatment outcomes for eight pediatric patients who received Ivabradine for JET.
• Comparison of Ivabradine's effectiveness against amiodarone, including one case requiring combined therapy.

Main Results:

• All eight pediatric patients with post-operative JET responded to Ivabradine, achieving initial rate control.
• One patient experienced JET recurrence 10 hours after Ivabradine administration.
• Combined Ivabradine and amiodarone therapy led to sinus rhythm remission in the recurrent case.

Conclusions:

• Ivabradine demonstrates potential as an effective alternative treatment for pediatric post-operative JET.
• Further research is warranted to confirm Ivabradine's role in managing this critical condition.